RTGN

$3.99-0.00%visit website

RetinalGenix Technologies Inc.

Market Cap

$75M

Live price × Finnhub shares (2026-09-22)

Sector

Health Care

Industry

Health Care

Beta (raw)

-2.39

56mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	20	35	117	66	239
Total operating expenses	568	622	589	303	2,083
Interest expense	0.96	1.07	1.26	3.96	7.24
Net income	(569)	(623)	(590)	(307)	(2,090)
EPS (basic) ($)	(0.03)		(0.03)	(0.02)	(0.11)
EPS (diluted) ($)	(0.03)		(0.03)	(0.02)	(0.11)
Weighted avg. shares (basic)	18,580		18,755	18,808
Weighted avg. shares (diluted)	18,580		18,755	18,808

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 20 more quarters, back to Sep 2020, with Tormere Pro.